Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Tabletop Centrifuge

By Drug Discovery Trends Editor | June 7, 2012

The Optima MAX-TL tabletop ultracentrifuge, from Beckman Coulter Life Sciences, delivers optimum functionality and efficiency within a compact and quiet package. Joining the Optima line of floor and tabletop ultracentrifuges, this entry-level instrument offers context-sensitive onscreen help and is available in multiple native languages to meet a full range of separation requirements in a user-friendly environment.

Users can set multiple programs of up to five steps each using an easily navigated, full-color LCD touch-screen accessible in nine languages: English, Spanish, German, Japanese, French, Italian, Russian, Portuguese and Chinese (simplified).

Fully compatible with Beckman Coulter TL labware and fixed-angle, swinging bucket and unique near-vertical tube (NVT) rotors, the Optima MAX-TL can be used in applications including separation of subcellular particles, viruses and viral particles, rate-zonal separation of proteins in sucrose gradient, separation of lipoproteins, pelleting of RNA through a CsCl gradient, isopycnic separation of plasmid DNA and others.

With a maximum speed of 120,000 rpm and maximum rcf of 657,000 x g, the instruments control speed within ±50 rpm of set point. Temperatures can be set from 0° to 40°C in 1°C increments, and controlled within ±2°C of set point (after equilibrium). The units operate in ambient temperatures from 15° to 35°C. Thermoelectric refrigeration eliminates CFCs and ODCs.

Beckman Coulter Optima MAX-TL ultracentrifuges fit in a standard BioSafety* hood, include HEPA filtration (filter available separately), and can use BioSafe* centrifuge tubes and fluid containment annulus rotors. Operating sound level is <47dBa.

“The Optima MAX-TL tabletop is an instrument for those working with smaller sample sizes and fills out our best-in-class line of ultracentrifuges,” noted Patrick O’Donnell, senior global manager of marketing. “The unit’s features and user-friendly qualities will make it of great service to researchers.”

Market-leading Optima X Series floor models, including the XE and XPN, and Optima MAX Series tabletop models, including the Optima MAX-XP and the new MAX-TL, comprise a complete line of ultracentrifuges. Total system design integrates instrument, rotors and labware to provide unparalleled performance and usability across the full range.

Beckman Coulter Life Sciences


Filed Under: Drug Discovery

 

Related Articles Read More >

Sai Life Sciences exec: GLP-1 boom has ‘exploded the peptide field’ as firm opens new center
Novartis in the Pharma 50
Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE